Macroaxis: Personalized Investing
Simple Personalized Investing

SP 500   1,669   2.87  Index Moved Up 0.17%
MDZ-A ECG ITM POW Technology Wireless Synthetics Moderate 
United States GSPC USD ...  |  Investing Themes


Processing
Collecting data for ECG

Merus quote and profile

 
 Companies |  Insiders  | Dashboard  
     
2.0
  
STOCK
0.00  No Change   0.00%  
Year To Date
0.842.38
Trading Day 
2.02.0
May 21 2013 

Diversification Suggestion

Use Merus to protect against small markets fluctuations. The stock experiences normal downward trend, but the immediate impact on correlations cannot be determined at the moment
Check current 30 days Merus correlation with market (S&P 500)
1 Month Beta 0.0  
Unless we do not have data at the moment the returns on S&P 500 and Merus are completely uncorrelated
Merus Labs International Inc not significant BetaMerus Labs International Beta Legend
ECG Canada Toronto #B77PZ45CA
Merus Labs International Inc
Services
Marketing Services
Benchmark S&P 500
http://www.meruslabs.com
Contact Number: 416. 593. 3725
Currency: CAD - Canadian Dollar
Traded on Toronto Stock Exchange
    
Shares Outstanding30.18 M
Revenue17.09 M
EBITDA8.96 M
Cash and Equivalents1.68 M
 Canada Canada   1.03 % Macroaxis: change 1.03 Moved Up  
 
 United States SP 500   0.17 % Macroaxis: 0.17 Moved Up  
 
 thisGreen ECG ECG.TO agains markets  0.00 % No Change  
Compare to Competition Get Alpha   Get Advice

Merus Leadership

CA, CFA CEO and President and Director
Ahmad Doroudian Executive Vice Chairman
CA BAcc CFO

Merus Summary

Merus Labs International Inc [ECG] is traded on Toronto Stock Exchange in Canada. It is located in Toronto, ON MT A and employs 2 people. The company currently falls under 'Micro-Cap' category with current market capitalization of 60.37 M. Merus Labs International Inc operates under Services sector and is part of Marketing Services industry. This company has 30.18 M outstanding shares.
Merus Labs International Inc., a specialty pharmaceutical company, engages in the acquisition and licensing of branded prescription pharmaceutical solutions in the United States, Canada, and Europe. more
Follow Merus with Macroaxis syndicated feed, custom widget, or your favorite custom stock ticker
Add To Reader
 
Add Merus to your reader
 

Merus Research Report

Merus vs. MDC Partners

Correlation analysis and fundamentals comparison between Merus Labs International and MDC Partners

Merus Executives

CA BAcc CFO

Merus Directors

Ulrich Schoeberl Managing Director of European Operations

Merus Management

Ali Cma VP of Bus. Devel. and Commercial Operations

Merus Fundamentals

Cash Flow from Operations vs Total Debt
Z Score vs Market Capitalization
Cash Flow from Operations vs Price to Earning
Earnings Per Share vs Market Capitalization

 
Analytics
Risk Adjusted Returns Landscape
Live Efficient Frontier
Market Correlation Analysis
Watchlist Analysis
Financial Content
Portfolio Estimation and Projections
Portfolio Theme Builder
 
 
Research Modules
Equities Backtesting Analysis
Instant Retirement Optimizer
Cross-portfolio RSS and Mobile Access
Company, fund, and ETF Directory
Financial Advisor Directory
Insider and Manager Directory
Wealth Management
 Gadgets, Widgets, and Apps          
  
 
Services And Technology
Frequently Asked Questions
Quick Product Tour
Product Technology Overview
Solution Methodology
Plans and Pricing
 
Free Investor Tools
World Market Correlations
Instant Equity Comparator
Watchlist Analysis
Position Suggestions
Equity Alpha Analysis
 
About Us
About Macroaxis
Contact Us
Product Terms Of Use
Service Privacy Policy
Advertising Opportunities
Content

Thanks for checking out Macroaxis

Tell us what you like and what you don't like. We promise we'll not only listen but write you back

Contact Us
Macroaxis is user-driven community of investors. We appreciate any feedback or comment you can provide. Please fill out our quick survey to help us provide your with a better service and user experience

Fill Out Quick Survey
Most of the functionality on our site is free to use. However we do provide premium service to sophisticated investors. Our premium subscription will give you unprecedented capabilities to optimize your portfolios using robust financial analysis toolkit, fast mean-variance optimization engine, and proven portfolio theory

Go Premium